Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Copple

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 27, 2017
Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune CellsMonday O Ogese, Lee Faulkner, Roz E Jenkins, et al.
Journal of Medicinal Chemistry|February 25, 2016
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction SitesMichael H L Wong, Holly K Bryan, Ian M Copple, et al.
Redox Biology|October 18, 2025
Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseasesMonika Jakubowska, Vera Marisa Costa, Wojciech Krzeptowski, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Examination of the cytotoxic and embryotoxic potential and underlying mechanisms of next-generation synthetic trioxolane and tetraoxane antimalarialsIan M Copple, Amy E Mercer, James Firman, et al.
Scientific Reports|April 6, 2018
NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosisAdam Lister, Soline Bourgeois, Pedro H Imenez Silva, et al.
Kidney International|October 1, 2015
Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidneyLuke M Shelton, Adam Lister, Joanne Walsh, et al.
Redox Biology|April 21, 2024
Biomarkers of NRF2 signalling: Current status and future challengesChristina Morgenstern, Isabel Lastres-Becker, Birsen Can Demirdöğen, et al.
Oncotarget|June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget|February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Archives of Toxicology|November 15, 2018
Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injuryIan M Copple, Wouter den Hollander, Giulia Callegaro, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 27, 2017
Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune CellsMonday O Ogese, Lee Faulkner, Roz E Jenkins, et al.
Journal of Medicinal Chemistry|February 25, 2016
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction SitesMichael H L Wong, Holly K Bryan, Ian M Copple, et al.
Redox Biology|October 18, 2025
Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseasesMonika Jakubowska, Vera Marisa Costa, Wojciech Krzeptowski, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Examination of the cytotoxic and embryotoxic potential and underlying mechanisms of next-generation synthetic trioxolane and tetraoxane antimalarialsIan M Copple, Amy E Mercer, James Firman, et al.
Scientific Reports|April 6, 2018
NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosisAdam Lister, Soline Bourgeois, Pedro H Imenez Silva, et al.
Kidney International|October 1, 2015
Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidneyLuke M Shelton, Adam Lister, Joanne Walsh, et al.
Redox Biology|April 21, 2024
Biomarkers of NRF2 signalling: Current status and future challengesChristina Morgenstern, Isabel Lastres-Becker, Birsen Can Demirdöğen, et al.
Oncotarget|June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget|February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancerJonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Archives of Toxicology|November 15, 2018
Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injuryIan M Copple, Wouter den Hollander, Giulia Callegaro, et al.
Pageof 5